Vertigo, a sensation of feeling off balance often characterized by a dizzy spell or feeling like the world around you is spinning, is a common complaint presented in medical settings. Despite its prevalence, it remains a challenging condition to diagnose and manage due to the myriad of potential causes and its subjective nature. This article aims to provide healthcare professionals with a comprehensive clinical approach to vertigo, from understanding its pathophysiology to diagnosing and managing the condition.
Vertigo is a subtype of dizziness, distinct from non-specific lightheadedness or imbalance. It is typically caused by a dysfunction in the vestibular system, which includes parts of the inner ear and brain that process sensory information involved with controlling balance and eye movements. Vertigo is further classified into peripheral and central based on the site of the lesion.
Peripheral vertigo is the most common type, accounting for 93% of cases. It arises due to disorders affecting the inner ear or vestibular nerve. Conditions like benign paroxysmal positional vertigo (BPPV), Meniere's disease, and vestibular neuritis fall under this category. Patients often present with acute, severe vertigo spells lasting minutes to hours, accompanied by nausea and vomiting. Auditory symptoms may also be present.
Central vertigo, on the other hand, is caused by disorders affecting the balance centers of the brain, such as the cerebellum and brainstem. Conditions like stroke, multiple sclerosis, and migraines can lead to central vertigo. Symptoms are often less intense but more persistent, with associated neurological signs like diplopia, dysarthria, or ataxia.
An accurate history and physical examination are crucial in diagnosing vertigo. The onset, duration, frequency, and associated symptoms can help differentiate between peripheral and central causes. For instance, episodic vertigo with a known trigger suggests BPPV, while vertigo with hearing loss and tinnitus may indicate Meniere's disease.
The physical examination should include a thorough neuro-otologic examination, including the Dix-Hallpike maneuver for BPPV and the head impulse test for vestibular neuritis. Neurological examination can help identify signs of central causes.
While the clinical evaluation can provide valuable clues, further investigations may be necessary for a definitive diagnosis. Audiometry can assess for hearing loss in Meniere's disease, while vestibular function tests like videonystagmography (VNG) or caloric testing can help confirm a peripheral cause. Neuroimaging, such as MRI, is indicated in suspected central vertigo or when vascular risk factors are present.
Management of vertigo is primarily directed at the underlying cause. In BPPV, canalith repositioning maneuvers like the Epley maneuver can be curative. Vestibular suppressants like meclizine can provide symptomatic relief, but their long-term use is discouraged due to potential impairment of vestibular compensation.
Meniere's disease can be managed with dietary modifications, diuretics, and intratympanic steroid injections. In refractory cases, surgical interventions may be considered. Central vertigo requires management of the underlying neurological condition.
Importantly, vestibular rehabilitation should be part of the management plan for all patients with vertigo. It includes exercises that promote central compensation for the loss of vestibular function, thus improving balance and reducing the risk of falls.
Vertigo is a complex clinical entity that requires a thorough understanding of its pathophysiology, careful clinical evaluation, and appropriate diagnostic workup. By adopting a systematic approach, healthcare professionals can accurately diagnose and manage this condition, thereby improving patient outcomes. As our understanding of vertigo continues to evolve, it is crucial for healthcare professionals to stay updated on the latest diagnostic and therapeutic strategies to provide the best possible care for their patients.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation